Investors attending any of the above conferences who would like to meet with OXB are welcome to contact the Company’s IR team via ir@oxb.com. Live webcasts and recordings of presentations, where ...
Progression to full ownership aligns with global strategy and supports long-term growth in the viral vector manufacturing market Oxford, UK – 23 June 2025: OXB (LSE: OXB) (“the Company”), a global ...
OXB announces date for Capital Markets Day and participation in upcoming investor conferences Oxford, UK – 3 March 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results